IP Verse

Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - EP3492109

The patent EP3492109 was granted to Moderna on Mar 4, 2020. The application was originally filed on Oct 3, 2012 under application number EP18213451A. The patent is currently recorded with a legal status of "Revoked".

EP3492109

MODERNA
Application Number
EP18213451A
Filing Date
Oct 3, 2012
Status
Revoked
Aug 18, 2023
Grant Date
Mar 4, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHDec 4, 2020WILKADMISSIBLE
SANOFIDec 4, 2020CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (51) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20100404413-
DESCRIPTIONUS2011177495
DESCRIPTIONUS2011237975
DESCRIPTIONUS4270537
DESCRIPTIONUS4596556
DESCRIPTIONUS4790824
DESCRIPTIONUS4886499
DESCRIPTIONUS4940460
DESCRIPTIONUS4941880
DESCRIPTIONUS5015235
DESCRIPTIONUS5064413
DESCRIPTIONUS5141496
DESCRIPTIONUS5190521
DESCRIPTIONUS5208020
DESCRIPTIONUS5312335
DESCRIPTIONUS5328483
DESCRIPTIONUS5334144
DESCRIPTIONUS5339163
DESCRIPTIONUS5383851
DESCRIPTIONUS5417662
DESCRIPTIONUS5466220
DESCRIPTIONUS5475092
DESCRIPTIONUS5480381
DESCRIPTIONUS5503627
DESCRIPTIONUS5520639
DESCRIPTIONUS5527288
DESCRIPTIONUS5569189
DESCRIPTIONUS5585499
DESCRIPTIONUS5599302
DESCRIPTIONUS5649912
DESCRIPTIONUS5704911
DESCRIPTIONUS5846545
DESCRIPTIONUS5893397
DESCRIPTIONUS5993412
DESCRIPTIONUS7893227
DESCRIPTIONWO2012045075
DESCRIPTIONWO2012045082
DESCRIPTIONWO9713537
DESCRIPTIONWO9737705
DESCRIPTIONWO9934850
OPPOSITIONEP2578685
OPPOSITIONEP2622064
OPPOSITIONWO2007024708
OPPOSITIONWO2012019168
OPPOSITIONWO2012045075
OPPOSITIONWO2012045082
OPPOSITIONWO2012135805
OPPOSITIONWO2013052523
OTHERUS2011143397
OTHERWO2007024708
SEARCHWO2011012316

Non-Patent Literature (NPL) Citations (33) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALBRECHT, Immunotherapy, (20100000), vol. 2, no. 6, pages 795 - 8-
DESCRIPTION- ALTSCHUL, S. F. et al., J. Molec. Biol., (19900000), vol. 215, page 403-
DESCRIPTION- BERGE et al., Journal of Pharmaceutical Science, (19770000), vol. 66, pages 1 - 19-
DESCRIPTION- CARILLO et al., SIAM J. Applied Math., (19880000), vol. 48, page 1073-
DESCRIPTION- CARILLO, H.; LIPMAN, D., SIAM J Applied Math., (19880000), vol. 48, page 1073-
DESCRIPTION- CARON et al., Mol Ther., (20010000), vol. 3, no. 3, pages 310 - 8-
DESCRIPTION- CHELLISERRYKATTIL; ELLINGTON, Nature Biotechnology, (20040000), vol. 22, no. 9, pages 1155 - 1160-
DESCRIPTION- DESHAYES et al., Cell Mol Life Sci, (20050000), vol. 62, no. 16, pages 1839 - 49-
DESCRIPTION- DEVEREUX, J. et al., Nucleic Acids Research, (19840000), vol. 12, no. 1, page 387-
DESCRIPTION- EL-ANDALOUSSI et al., Curr Pharm Des., (20050000), vol. 11, no. 28, pages 3597 - 611-
DESCRIPTION- ESVELT et al., Nature, (20110000), vol. 472, no. 7344, pages 499 - 503-
DESCRIPTION- FUKUHARA et al., Biochemistry, (19620000), vol. 1, no. 4, pages 563 - 568-
DESCRIPTION- KARIKO et al., Immunity, (20050000), vol. 23, pages 165 - 175-
DESCRIPTION- KARIKO K et al., Immunity, (20050000), vol. 23, pages 165 - 75-
DESCRIPTION- KARIKO K et al., Mol Ther, (20080000), vol. 16, pages 1833 - 40-
DESCRIPTION- MEYERS; MILLER, CABIOS, (19890000), vol. 4, pages 11 - 17-
DESCRIPTION- MUSUNURU K et al., "From noncoding variant to phenotype via SORTI at the lp 13 cholesterol locus", Nature, (20100000), vol. 466, pages 714 - 721-
DESCRIPTION- OGATA et al., J. Org. Chem., (20090000), vol. 74, pages 2585 - 2588-
DESCRIPTION- OGATA et al., Journal of Organic Chemistry, (20090000), vol. 74, pages 2585 - 2588-
DESCRIPTION- Oligonucleotide synthesis: methods and applications, Methods in Molecular Biology, Humana Press, (20050000), vol. 288-
DESCRIPTION- PADILLA; SOUSA, Nucleic Acids Research, (20020000), vol. 30, no. 24, page el28-
DESCRIPTION- "Pro-drugs as Novel Delivery Systems", T. HIGUCHI; V. STELLA, A.C.S. Symposium Series, and in Bioreversible Carriers in Drug Design, American Pharmaceutical Association and Pergamon Press, (19870000), vol. 14-
DESCRIPTION- PURMAL et al., Nucl. Acids Res., (19940000), vol. 22, no. 1, pages 72 - 78-
DESCRIPTION- PURMAL et al., Nucleic Acids Research, (19940000), vol. 22, no. 1, pages 72 - 78-
DESCRIPTION- Remington's Pharmaceutical Sciences, Mack Publishing Company, (19850000), page 1418-
DESCRIPTION- ROBBINS et al., Oligonucleotides, (20090000), vol. 19, pages 89 - 102-
DESCRIPTION- ROZENSKI, J; CRAIN, P; MCCLOSKEY, J., "The RNA Modification Database: 1999 update", Nucl Acids Res, (19990000), vol. 27, pages 196 - 197-
DESCRIPTION- WARREN et al., Cell Stem Cell, (20100000), vol. 7, pages 618 - 630-
DESCRIPTION- XU et al., Tetrahedron, (19920000), vol. 48, no. 9, pages 1729 - 1740-
OPPOSITION- "1-Methylpseudouridine", Pubchem, (20201201), Database accession no. CID 99543, XP055763132-
OPPOSITION- MIGNONE et al., "Untranslated regions of mRNAs", Genome Biology, (20020000), vol. 3, no. 3, XP055763129-
SEARCH- LUIGI WARREN ET AL, "Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA", vol. 7, no. 5, doi:10.1016/J.STEM.2010.08.012, ISSN 1875-9777, (20101105), pages 618 - 630, CELL STEM CELL, CELL PRESS, UNITED STATES, URL: http://www.sciencedirect.com/science/article/pii/S1934590910004340, XP002693059 [A] 1-9 * abstract *
SEARCH- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 16, no. 11, doi:10.1038/MT.2008.200, ISSN 1525-0024, (20081101), pages 1833 - 1840, (20080916), XP002598556 [A] 1-9 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents